Benjamin F. Edwards & Company, Inc. Gsk PLC Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $49,997 - $56,798	-1,189 Reduced 12.06%	8,672 $377,000
Q1 2022 May 04, 2022	BUY	$40.23 - $47.74 $207,627 - $246,386	5,161 Added 109.81%	9,861 $430,000
Q4 2021 Feb 07, 2022	SELL	$38.88 - $45.31 $1,827 - $2,129	-47 Reduced 0.99%	4,700 $207,000
Q3 2021 Nov 02, 2021	BUY	$38.79 - $43.16 $16,446 - $18,299	424 Added 9.81%	4,747 $181,000
Q2 2021 Aug 11, 2021	SELL	$36.52 - $41.46 $10,408 - $11,816	-285 Reduced 6.18%	4,323 $172,000
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $24,982 - $29,167	-729 Reduced 13.66%	4,608 $164,000
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $33,899 - $39,740	995 Added 22.92%	5,337 $196,000
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $33,613 - $37,917	-882 Reduced 16.88%	4,342 $163,000
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $19,692 - $22,661	-520 Reduced 9.05%	5,224 $213,000
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $13,020 - $19,580	-401 Reduced 6.53%	5,744 $218,000
Q4 2019 Feb 06, 2020	BUY	$42.0 - $48.25 $24,570 - $28,226	585 Added 10.52%	6,145 $289,000
Q3 2019 Nov 05, 2019	SELL	$40.46 - $43.52 $2,265 - $2,437	-56 Reduced 1.0%	5,560 $237,000
Q2 2019 Aug 08, 2019	SELL	$39.4 - $42.7 $49,486 - $53,631	-1,256 Reduced 18.28%	5,616 $225,000
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $542,834 - $600,819	-14,074 Reduced 67.19%	6,872 $287,000
Q4 2018 Jan 31, 2019	BUY	$37.8 - $42.69 $96,276 - $108,731	2,547 Added 13.84%	20,946 $800,000
Q3 2018 Oct 29, 2018	BUY	$39.75 - $42.69 $18,245 - $19,594	459 Added 2.56%	18,399 $739,000
Q2 2018 Jul 19, 2018	SELL	$39.61 - $42.76 $186,840 - $201,698	-4,717 Reduced 20.82%	17,940 $723,000
Q1 2018 Apr 17, 2018	BUY	$36.18 - $40.15 $254,019 - $281,893	7,021 Added 44.9%	22,657 $885,000
Q4 2017 Jan 17, 2018	SELL	$35.34 - $41.9 $303,535 - $359,879	-8,589 Reduced 35.46%	15,636 $555,000
Q3 2017 Oct 24, 2017	BUY	$39.44 - $41.55 $955,434 - $1.01 Million	24,225	24,225 $984,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account